√¶SYSTEMIC DISEASE AND ORAL BACTERIA

Rheumatoid arthritis and the role of
oral bacteria
Juan Pablo Loyola-Rodriguez1*, Rita Elizabeth Martinez-
Martinez1, Carlos Abud-Mendoza2, Nuria PatinÀú o-Marin1 and
Gregory J. Seymour3
1Master‚Äôs Degree in Dental Science Program with specialization in Advanced General Dentistry,
Faculty of Dentistry; 2Regional Unit of Rheumatology and Osteoporosis, Central Hospital Dr. Ignacio
Morones Prieto, both at San Luis Potosi University, Mexico; 3Faculty of Dentistry, University of Otago,
Dunedin, New Zealand

Rheumatoid arthritis (RA) and periodontal disease (PD) have shown similar physiopathologic mechanisms
such as chronic inflammation with adjacent bone resorption in an immunogenetically susceptible host;
however, PD has a well-recognized bacterial etiology while the cause of RA is unclear. Some reports have
indicated that an infectious agent in a susceptible host could be one possible trigger factor for RA, and it has
been suggested that oral microorganisms, specialty periodontal bacteria could be the infectious agent (mainly
Porphyromonas gingivalis). It has been reported that PD is more frequent and more severe in patients with
RA, suggesting a positive association between both diseases. There have been reports regarding the detection
of antibodies against periodontal bacteria while other studies have identified periodontal bacterial DNA in
serum and synovial fluid of RA patients and have explored the possible pathways of transport of periodontal
bacterial DNA. In conclusion, there is no question that RA and PD have pathologic features in common and
there is strong evidence of an association between both diseases, but further studies, including experimental
models, are needed to demonstrate the arthritogenicity of oral microorganisms.

Keywords: rheumatoid arthritis; periodontal disease; oral bacteria; bacterial DNA

Published: 21 December 2010

Periodontal disease (PD) is one of the most common

chronic disorders of infectious origin known in
humans with a prevalence of 1060% in adults
depending on the diagnostic criteria (1). It includes gin-
givitis, an inflammatory condition of the soft tissues
surrounding the tooth and periodontitis that involves loss
of alveolar bone. Patients affected by PD respond to
bacterial dental plaque biofilm by mobilizing their defen-
sive cells and releasing cytokines like interleukin-1b,
tumor necrosis factor-a, and interleukin-6, which lead
to tissue destruction by stimulating the production
of the collagenolytic enzymes: matrix metalloproteinases
(MMPs) (2).

Rheumatoid arthritis (RA) is considered an autoim-
mune disease and while genetic factors are important in
the development of
the disease, not all susceptible
patients develop RA (3, 4). RA is characterized by
inflammation of the synovial membrane, leading to an
invasion of the synovial tissue into the adjacent cartilage
matrix with degradation of the articular cartilage and

bone destruction. It affects approximately 1% of the adult
population and environmental factors have also been
shown to play a role in the etiology of RA (5). It has been
proposed that synovial and adjacent soft tissue inflam-
mation may be initiated by a number of microbial factors,
including bacterial DNA, CpG motifs, heat
shock
proteins, and lipopolysaccharides (69). The thought
that RA may be triggered by an unknown infectious agent
has been a longstanding concept in its pathogenesis. It has
been well established that in the case of refractory
RA, infectious agents triggering joint inflammation are
involved. Gastrointestinal and urogenital bacterial species
such as Yersinia, Salmonella, Camphylobacter, Shigella,
and Chlamydia have all been associated with RA (1015).
The pathophysiological mechanisms of cartilage and
bone destruction in RA are not exactly understood.
However, it is known that MMPs, cathepsins, and osteo-
clast activation contribute to bone resorption (16, 17).
A number of cytokines like TNF-a, IL-1, and macrophage
colony-stimulating factor (MCSF) are also involved (18).

Journal of Oral Microbiology 2010. # 2010 Juan Pablo Loyola-Rodriguez et al. This is an Open Access article distributed under the terms of the Creative
Commons Attribution-Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and
Citation: Journal of Oral Microbiology 2010, 2: 5784 - DOI: 10.3402/jom.v2i0.5784
reproduction in any medium, provided the original work is properly cited.

1

(page number not for citation purpose)

Juan Pablo Loyola-Rodriguez et al.

Epidemiological association between
rheumatoid arthritis (RA) and periodontal
disease (PD)
There have been recent reports suggesting a significant
association between RA and PD (19, 20). The hypothesis
that RA is an infectious disease has been postulated
for over 70 years (21). It is proposed that RA patients
have direct contact with microorganisms and their viru-
lence factors, which activate an immune response in the
synovial membrane with the accumulation of immuno-
competent T- and B-cells. This reaction is mediated by
neutrophils, monocytes, and lymphocytes (both T and
B), leading to the release of proteinases, cytokines, and
prostaglandins that stimulate osteoclast activity and bone
resorption (22). While some reports have indicated that an
infectious agent in a susceptible host could be one possible
trigger factor for RA (23), the published studies vary
widely with respect to study design and methods used for
the diagnoses of RA and PD, which in turn make it
difficult to ascertain the association between RA and PD.
The clinical designs most commonly used were case-
control and cross-sectional studies with the main concern
being the criteria used to define control subjects. Most of
the volunteers were recruited from the staff at the study
centers or were patients attending dental clinics, such that
the results of these studies need to be treated with caution.
trials have shown that
individuals with RA are more likely to experience
moderate to severe PD compared with healthy subjects,
while others have reported a high incidence of RA in
patients with periodontitis. There is evidence that RA
patients have deeper periodontal pockets (OR2.47) and
greater severity of periodontitis (OR2.27) (24). In a
recent case-control study that involved 57 RA patients
and 52 healthy subjects, RA patients showed a positive
association (OR8.05) with PD (25).

Some prospective clinical

Common pathophysiologic mechanisms
The fact that RA and PD have similar physiopathologic
mechanisms, such as chronic inflammation with adjacent
bone resorption, has led some authors to suggest that RA
and PD are a variety of the same disease. Both are
chronic inflammatory reactions in an immunogenetically
susceptible host (19); however, PD has a well-recognized
bacterial etiology while on the other hand the cause of
RA is unclear. It has been accepted that many different
arthritogenic stimuli exist that could include exogenous
infectious factors (26) or endogenous substances such as
connective tissue proteins (collagens and proteoglycans)
and altered immunoglobulins resulting in an autoimmune
response (22).

Periodontal bacteria are able to activate immunologi-
cal responses by different mechanisms; one such mechan-
ism includes the ability of Porphyromonas gingivalis to
produce a peptidyl arginine deaminase enzyme (PAD),

which leads to citrullination of host proteins and the
production of putative autoantigens (20). At the same
time, antibodies against heat shock proteins (hsp 70) of
Prevotella nigrescens and Prevotella intermedia have been
found in synovial fluid of patients with RA possibly
triggering an immune response (27, 28). It has also been
reported that human leukocyte antigen (HLA) genes are
directly associated with RA and PD. These are powerful
risk factors for both diseases, further suggesting a close
connection. The main HLA marker for both diseases is
the highly polymorphic HLA-DRB1 locus (29, 30).

Another possible biological link is the fact that IL-1
cytokines are the main mediators of
the immune
response, inflammation, and tissue destruction in both
diseases. There are increased levels of IL-1b in synovial
tissue macrophages and gingival crevicular fluid in
patients with RA and PD (22). Studies in animal models
have shown high levels of tissue MMPs, tumor necrosis
factor-a, and IL-1b in both diseases indicating a similar
pattern of tissue destruction (31).

Mechanisms of tissue destruction in rheumatoid
arthritis (RA) and periodontal disease (PD)
The mechanisms of alveolar bone destruction in PD and
articular surfaces in RA are similar. There is an over-
production of a variety of cytokines and MMPs that
appear to be common in both diseases (22). PD and RA
both have persistent high levels of proinflammatory
cytokines, including IL-1b and tumor necrosis factor-
alpha (TNF-a), and low levels of cytokines that suppress
the immunoinflammatory response such as IL-10 and
transforming growth factor-b (TGF-b) (32). These cyto-
kines, together with low levels of metalloproteinases
inhibitors (TIMPs), and high levels of MMPs and
prostaglandin E2 (PGE2) are associated with disease
activity (22).

The link between periodontal disease (PD) and
rheumatoid arthritis (RA): oral bacteria
Most of the clinical studies that have implicated specific
infective triggers for RA have relied on serological
methods to detect prior exposure to bacteria or to viruses.
These studies have either detected antibodies against a
target microorganism or identified genetic material
in
blood or synovial fluid (3337). There have been studies
exploring the association of periodontopathogenic bac-
teria with RA, these were mainly focused on the detection
of antibodies against the different bacteria associated
with periodontitis in both synovial fluid and serum,
Table 1. In a case-control study, serum antibodies against
disease-producing periodontal bacteria were identified
more frequently in subjects affected by RA and period-
ontitis than control subjects (38, 39). In particular anti-P.
gingivalis, antibodies have been reported to be more
frequent in RA subjects compared with controls and that

2

(page number not for citation purpose)

Citation: Journal of Oral Microbiology 2010, 2: 5784 - DOI: 10.3402/jom.v2i0.5784

RA and oral bacteria

Table 1. Oral bacteria associated to rheumatoid arthritis patients in clinical studies

Study design

Assay used

Sampling site

Associated bacteria

Reference

Case-control

Nephelometry and

Antibodies in serum

Porphyromonas gingivalis

Hitchon et al. (49)

ELISA

Cross-sectional PCR

Bacterial DNA in subgingival

Prevotella intermedia,

Martinez-Martinez et al.

Case-control

ELISA

Case-control

ELISA and

Immunoblotting

plaque, serum and synovial

Porphyromonas gingivalis,

(41)

fluid
Antibodies in serum

Antibodies in serum

Prevotella nigrescens
Porphyromonas gingivalis

Mikuls et al. (40)

Citrullinated alpha-enolase

Lundberg et al. (50)

peptide and cross reactivity to

Porphyromonas gingivalis

Case-control

Checkerboard DNA-

Bacterial DNA in serum and

Porphyromonas gingivalis,

Moen et al. (39)

DNA-hybridization

synovial fluid

Tanerella forsythensis, Prevotella

Case-control

ELISA

Antibodies in serum

Case-control

Agar plates

Bacterial growth

Intermedia

Porphyromonas gingivalis,
Prevotella intermedia, Prevotella

melaninogenica, bacteroides,

Actinobacillus

actinomycetemcomitans

Staphylococcus aureus

Cross-sectional

ELISA

Antibodies in serum and

Bacteroides forsythus and

Case-control

ELISA

Antibodies in serum

synovial fluid

Case-control

Agar plates

Bacterial growth

Prevotella intermedia

Actinobacillus
actinomycetemcomitans

Staphylococcus aureus

Ogrendik et al. (38)

Bassetti et al. (70)

Moen et al. (45)

Yoshida et al. (28)

Jacobson et al. (56)

Case-control

Case-control

ELISA

ELISA

Antibodies in serum

Antibodies in serum

Porphyromonas gingivalis

Yusof et al. (34)

B. gingivalis and Aubacterium

Tolo and Jorkjend (33)

saburreum

the titer of RA-related autoantibodies and C-reactive
protein concentrations are also higher in individuals
infected with P. gingivalis suggesting that this organism
plays a role in disease risk and progression in RA (40).

On the other hand,

it has been proposed that the
detection of bacterial DNA in the synovial fluid of RA
patients is more important than the detection of anti-
bodies as it suggests the transport of bacterial DNA from
sites of infection to the joints of RA patients. Recently,
there have been reports that have focused on the detection
of bacterial DNA in RA-affected joints using checker-
board DNADNA-hybridization or PCR assays (39, 41).
In this context, it has been reported that P. gingivalis,
Tannerella forsythia, and P. intermedia have been identi-
fied in synovial fluid samples from RA and psoriatic
arthritis patients using the checkerboard DNADNA-
hybridization assay (39). A recent cross-sectional study
involving 19 subjects with periodontitis and refractory
RA (these patients received intensive treatment with
disease-modifying antirheumatic drugs DMARDs: meth-
otrexate, sulfasazine, leflunomide, and chloroquine) has
shown that P. intermedia (89.4%), P. gingivalis (57.8%),
and P. nigrescens (21.0%), were frequently detected with
PCR (41). These two studies clearly demonstrate that

chromosomal DNA from bacteria associated with PD is
present in serum and synovial fluid from patients with
RA. Although bacterial DNA might be associated with
chronic inflammation of the joints,
it remains to be
determined whether these microbial factors are a cause or
are a result of the disease.

Synovial inflammation facilitates trapping of oral
bacterial DNA
In the early stages of PD, the epithelium ulcerates to
expose the underlying connective tissues and vasculature
to the subgingival biofilm, this then provides for the entry
of periodontopathic into the bloodstream during eating
and brushing (42, 43). It is well established that patients
affected by PD have frequent episodes of bacteremia. The
frequency of bacteremia after ultrasonic scaling is 13%,
after periodontal probing 20%, and after tooth brushing
it is 3% (42).

Finally, it has been reported that synovial inflamma-
tion in the joint affected by RA favors trapping of oral
bacterial DNAs (39). Hence, it is unknown whether the
presence of oral bacteria in the inflamed joint is a cause
or a result of the inflammation.

Citation: Journal of Oral Microbiology 2010, 2: 5784 - DOI: 10.3402/jom.v2i0.5784

(page number not for citation purpose)

3

Juan Pablo Loyola-Rodriguez et al.

Pathways of transport of bacterial DNA
There could be three possible pathways of transport of
periodontal bacterial DNA from periodontal sites to the
synovium:

1. As whole viable cells leading to infection in the
joint and reactivation of RA in spite of rheumatic
treatment.

2. Via intracellular capture by immune cells, as evi-
denced by the fact that synovial fluid contains
phagocytosed material including IgG, IgM, rheu-
matoid factor, fibrin, antinuclear factors, immune
complexes, and DNA particles.

3. Via free DNA transportation in the bloodstream

(39).

A number of different experiments have been carried out
to probe these potential pathways. These include inocu-
lation of synovial fluid in different culture media, under
aerobic, and anaerobic conditions. As no bacterial
growth was detected, these results suggest that there were
no viable bacterial cells in the samples studied. Isolated
leukocytes from whole blood have also been tested by
PCR to detect bacterial DNA and, again, there were no
positive samples to any periodontal bacterial species
studied suggesting that DNA does not
from
periodontal sites to joints inside immune cells. In the
absence of these two possible mechanisms,
it would
appear that the transport of bacterial DNA is as free
DNA (41).

travel

P. gingivalis and rheumatoid arthritis (RA)
P. gingivalis is the main organism associated with chronic
PD. It is a gram-negative anaerobic bacteria, the fimbriae
of which allow binding of the bacterial cell to host
proteins (44).

The IgG and IgA antibody levels against P. gingivalis,
together with other periodontopathic organisms such as
P. intermedia, P. nigrescens, and T. forsythia were higher in
serum and synovial fluid from RA patients when com-
pared with controls. The presence of these antibodies
could be important in the etiopathogenesis of RA and
could represent a potential connection between period-
ontal and joint diseases (38, 45). On the other hand, it has
been reported that the same level of IgG antibody against
P. gingivalis occurs in serum of patients with a rapidly
progressive form of periodontitis, RA, chronic period-
ontitis, and a control group (34). These authors did not
detect differences between RA subjects and the control
group, although this could be attributed to the study
design and the small sample size involved (34).

As mentioned previously, RA is an autoimmune disease
showing a reaction to citrullinated proteins. Citrullina-
tion, also termed deamination,
is a modification of
arginine side chains catalyzed by peptidylarginine deami-
nase (PAD) enzymes. This posttranslational modification
has the potential to alter the structure, antigenicity, and
function of proteins. In RA, antibodies to cyclic citrulli-
nated peptides are used in clinical diagnosis. The citrulli-
nated antigens are: fibrinogen, vimentin, collagen type II,
and alpha-enolase, all of which are expressed in the joint.
Antibodies to citrullinated fibrinogen and collagen type II
mediate inflammation by the formation of
immune
complexes, both in human and animal models, Table 2
(46). P. gingivalis produces a microbial enzyme, equivalent
to the human PAD enzyme. It has been thought to
represent a susceptibility factor for RA. The antigens
generated by this enzyme lead the production of rheuma-
toid factor and local inflammation of both the gingivae
and synovium (20). PAD leads to the citrullination of
putative RA autoantigen such as fibrin in the synovium,
which in association with major histocompatibility com-
plex molecules and antigen-presenting cells, leads to the

Table 2. Association of Porphyromonas gingivalis with arthritis in in vitro studies

Focus

Assay

Associated bacteria

Sample

Reference

Protein citrullination by P. gingivalis

Immunoblotting

Porphyromonas gingivalis Cell culture Wegner et al. (46)

and breaking tolerance in RA

Mass spectrometry

P gingivalis infection and its effects

Scanning electron microscopy

Porphyromonas gingivalis Cell culture Pischon et al. (52)

on cell cycle progression and

Double immunofluorescence

apoptosis of human articular
chondrocytes

Cytometry
TUNEL

Exacerbation of action of a

Western blot analysis

Western blot analysis

proapoptotic fibronectin on nitric

Immunofluorescence.

oxide by bacteria

Hyperinflammatory genotype and

functional interferences in innate

and adaptive immune responses

ELISA

ELISA

Porphyromonas gingivalis

Cell culture Ghosh et al., 2008. (53)

Streptococcus mutans

Porphyromonas gingivalis

Mice

Trombone et al. (31)

Aggregatibacter

actinomycetemcomitans

4

(page number not for citation purpose)

Citation: Journal of Oral Microbiology 2010, 2: 5784 - DOI: 10.3402/jom.v2i0.5784

production of anti-CCP antibody (47). In addition, it has
been suggested that the immune response to P. gingivalis
may be involved in breaking immune tolerance to
citrullinated antigens (48, 49). As well there are reports
of a similarity of sequence and cross-reactivity with
bacterial enolase (50).

chronic

Some studies have investigated the association between
P. gingivalis and RA in animal models. One recent study, in
which heat-killed P. gingivalis was injected into the backs
of DA rats, has shown that P. gingivalis promotes the
development of arthritis as measured by paw swelling (51).
This study clearly showed that a pre-existing, extra-
synovial
inflammatory lesion induced by
P. gingivalis promotes the development of arthritis in an
animal model (51). In another study, P. gingivalis and
Aggregatibacter actinomyctemcomitans were used to in-
duce periodontal disease in a mouse model. It was
observed that in a genetically susceptible mouse strain
the reaction was associated with higher levels of TNF-a,
IL-1b, IL-17, MMP-13, and RANKL, suggesting a shared
hyperinflammatory genotype and functional interferences
in innate and adaptive immune responses (31).

Another possible mechanism to explain the association
between P. gingivalis and RA is its effect on cell cycle
progression and apoptosis of human articular chondro-
cytes. Studies have shown that P. gingivalis can adhere to
and infect primary human chondrocytes affecting cell
cycle progression. In this context, P. gingivalis might
contribute to the tissue damage seen in RA (52). It has
also been shown that P. gingivalis can cause cell apoptosis
and the breakdown of extracellular matrices into macro-
molecular fragments. Fibronectin fragments are asso-
ciated with disease severity in both RA and PD but the
mechanism is unclear, Table 2 (53).

It has been reported that interleukin-17 (IL-17), a
proinflammatory cytokine secreted by the CD4() Th17
subset, contributes to bone destruction in RA but, at the
same time, it is essential in the host innate immune defense
against pathogens such as P. gingivalis (54). While recent
evidence has shown that Th17 cells are more osteoclasto-
genic than other T helper subsets such as Th1 or Th2 and
ablation of IL-17 signaling prior to the onset of infection
with P. gingivalis increases susceptibility to periodontal
bone loss (55), IL-17RA deficient mice showed enhanced
periodontal bone destruction suggesting a bone-protective
role for IL-17 (54).

Finally, IgG antibodies to the 40-kD heat shock protein,
from Aggregatibacter actinomycetemcomitans are signifi-
cantly higher in RA sera than in the sera of healthy
controls (28). Other bacteria such as Staphylococcus
aureus and Staphylococcus epidermidis have also been
cited as possible bacterial etiologic agents in late prosthetic
infections in RA patients (56, 57). It is also interesting to
note that both of these bacterial species can be found in the
mouths of some people.

RA and oral bacteria

Control of periodontal infection reduces active
rheumatoid arthritis (RA)
Recent studies have shown that control of periodontal
infection and inflammation by means of scaling, root
planing, and oral hygiene in subjects with moderate and
severe PD might contribute to a reduction in the signs
and symptoms of active RA in terms of a reduction in the
serum levels of TNF-a (58). In addition, recent clinical
trials have suggested that the treatment of PD might have
an important impact on RA severity (5860).

Dual purpose therapies based on
biological links
Tetracyclines, non-steroidal anti-inflammatory drugs
(NSAIDs), and biphosphonates (61) have all been used
in the treatment of both RA and PD. Tetracyclines are
active against gram-negative and gram-positive organ-
isms and have also been shown to inhibit the collagenase
activity of MMPs (20). These enzymes are responsible for
bone destruction in both diseases and it has been
reported that MMPs have an enhanced activity in the
synovium of patients with RA (62). Therefore, it follows
that tetracyclines may be useful in patients with RA and
PD, since they are effective against the putative micro-
organisms implicated in periodontitis and possibly in RA
and also in decreasing bone destruction by inhibiting
MMPs (63, 64).

NSAIDs act by inhibiting cycloxygenase, the enzyme
responsible for the biosynthesis of prostaglandins. Period-
ontally diseased tissues have high prostaglandin levels,
which are considered to be important mediators of bone
resorption in periodontitis (65). NSAIDs are commonly
used in the treatment of RA to reduce pain and inflamma-
tion. Some NSAIDs can directly inhibit the activation and
function of neutrophils (66), and can inhibit TNF-a
release from monocytes and natural killer cells (67). These
cycloxygenase independent effects may contribute to the
efficacy of NSAIDs in the treatment of RA.

Conclusions
There is no question that PD and RA have many
pathologic features in common. In the last few decades,
periodontal research has provided strong evidence for a
correlation between elevated concentrations of serum
antibodies against periodontal pathogens and disease
severity (34, 45, 68, 69). At the same time, some studies
have attempted to identify periodontopathic bacteria in
serum and synovial fluid samples from patients with RA
using molecular biological assays (39, 41). At the present
time however, the detection of microorganisms (viable
replicating form) or bacterial DNA in the synovium is
not necessarily indicative of an active role in the
pathogenesis of RA. While emerging evidence suggests
a strong association between the extent and severity of
PD in patients affected by RA,
this relationship is

Citation: Journal of Oral Microbiology 2010, 2: 5784 - DOI: 10.3402/jom.v2i0.5784

(page number not for citation purpose)

5

Juan Pablo Loyola-Rodriguez et al.

unlikely to be causal. Experimental models, especially
animal models, need to be established to demonstrate the
arthritogenicity of oral microorganisms more definitively.

Acknowledgements

This investigation was supported by FMSLP-2008-C01-87090,
SEP-UASLP-CA-84, and PIFI-2009-24MSU0011E.

Conflict of interest and source of funding
statement
There is no conflict of interests in the present study for
any of authors.

References

1. Papapanou PN. Periodontal diseases: epidemiology. Ann

Periodontol 1996; 1: 136.

2. Takashiba S, Naruishi K, Murayama Y. Perspective of cyto-
kine regulation for periodontal treatment: Ô¨Åbroblast biology.
J Periodontol 2003; 74: 10310.

3. Silman AJ, MacGregor AJ, Thompson W, Holligan S, Carthy D,
Farhan A, et al. Twin concordance rates for rheumatoid
arthritis: results from a nationwide study. Br J Rheumatol
1993; 32: 9037.

4. Bellamy N, Duffy D, Martin N, Mathews J. Rheumatoid
arthritis in twins: a study of aetiopathogenesis based on the
Australian twin registry. Ann Rheum Dis 1992; 51: 58893.

5. Alamanos Y, Drosos AA. Epidemiology of adult rheumatoid

arthritis. Autoimmun Rev 2005; 4: 1306.

6. Albani S, Carson DA, Roudier J. Genetic and environmental
factors in the immune pathogenesis of rheumatoid arthritis.
Rheum Dis Clin North Am 1992; 18: 72940.

7. Deng GM, Tarkowski A. The role of bacterial DNA in septic

arthritis. Int J Mol Med 2000; 6: 2933.

8. Deng GM, Tarkowski A. The features of arthritis induced
by CpG motifs in bacterial DNA. Arthritis Rheum 2000; 43:
35664.

9. Klareskog L, Padyukov L, Lorentzen J, Alfredsson L. Mechan-
isms of disease: genetic susceptibility and environmental triggers
in the development of rheumatoid arthritis. Nat Clin Pract
Rheumatol 2006; 2: 42533.

10. Bas S, Griffais R, Kvien TK, Glennas A, Melby K, Vischer TL.
AmpliÔ¨Åcation of plasmid and chromosome chlamydia DNA in
synovial Ô¨Çuid of patients with reactive arthritis and undiffer-
entiated seronegative oligoarthropathies. Arthritis Rheum 1995;
38: 100513.

11. Branigan PJ, Gerard HC, Hudson AP, Schumacher HR Jr,
Pando J. Comparison of synovial tissue and synovial Ô¨Çuid as the
source of nucleic acids for detection of Chlamydia trachomatis
by polymerase chain reaction. Arthritis Rheum 1996; 39:
17406.

12. Hyrich KL, Inman RD. Infectious agents in chronic rheumatic

diseases. Curr Opin Rheumatol 2001; 13: 3004.

13. Cuchacovich R, Japa S, Huang WQ, Calvo A, Vega L, Vargas
RB, et al. Detection of bacterial DNA in Latin America patients
with reactive arthritis by polymerase chain reaction and
sequencing analysis. J Rheumatol 2002; 29: 14269.

15. Cox CJ, Kempsell KE, Hill Gaston JS. Investigation of
infectious agents associated with arthritis by reverse transcrip-
tion PCR of bacterial rRNA. Arthritis Res Ther 2003; 5: R18.
16. Woolley DE, Tetlow LC. Observations on the microenviron-
mental nature of cartilage degradation in rheumatoid arthritis.
Ann Rheum Dis 1997; 56: 15161.

17. Haynes DR, Crotti TN, Loric M, Atkins GJ, Findlay DM.
Osteoprotegerin and receptor activator of nuclear factor kappaB
ligand (RANKL) regulate osteoclast formation by cells in
the human rheumatoid arthritic joint. Rheumatology 2001; 40:
62330.

18. Chu CQ, Field M, Allard S, Abney E, Feldmann M, Maini RN.
Detection of cytokines at the cartilage/pannus junctions in
patients with rheumatoid arthritis: implications for the role of
cytokines in cartilage destruction and repair. Br J Rheumatol
1992; 31: 65361.

19. Greenwald RA, Kirkwood K. Adult periodontitis as a model
for rheumatoid arthritis (with emphasis on treatment strategies).
J Reumatol 1999; 26: 16503.

20. Rosenstein ED, Greenwald RA, Kushner LJ, Weissmann G.
Hyphothesis: the humoral immune response to oral bacteria
provides a stimulus for the development of rheumatoid arthritis.
InÔ¨Çammation 2004; 28: 3118.

21. Ebringer A, Wilson C. HLA molecules, bacteria and auto-

immunity. J Med Microbiol 2000; 49: 30511.

22. Bartold PM, Marshall RI, Haynes DR. Periodontitis and
rheumatoid arthritis: a review. J Periodontol 2005; 76: 206674.
23. Carty SM, Snowden N, Silman AJ. Should infection still be
considered as the most likely triggering factor for rheumatoid
arthritis? Ann Rheum Dis 2003; 30: 4259.

24. Mercado F, Marshall RI, Klestov AC, Bartold PM. Is there a
relationship between rheumatoid arthritis and periodontal
disease? J Clin Periodontol 2000; 27: 26772.

25. Pischon N, Pischon T, Kro¬®ger J, Gu¬® lmez E, Kleber BM,
Bernimoulin JP, et al. Association among rheumatoid arthritis,
oral hygiene, and periodontitis. J Periodontol 2008; 79: 97986.
26. Carty SM, Snowden N, Silman AJ. Should infection still be
considered as the most likely triggering factor for rheumatoid
arthritis? Ann Rheum Dis 2004; 63: ii469.

27. Schett G, Redlich K, Xu Q, Bizan P, Groger M, Tohidast-Akrad
M, et al. Enhanced expression of heat shock protein 70 (hsp70)
and heat shock factor (HSF1) activation in rheumatoid arthritis
synovial tissue. Differential regulation of hsp70 expression and
hsf1 activation in synovial Ô¨Åbroblasts by proinÔ¨Çammatory
cytokines, shear stress, and antiinÔ¨Çammatory drugs. J Clin
Invest 1998; 102: 30111.

28. Yoshida A, Nakano Y, Yamashita T, Oho T,

Ito H,
Kondo M, et al. Immunodominant region of Actinobacillus
actinomycetemcomitans 40-kilodalton heat shock protein in
patients with rheumatoid arthritis. J Dent Res 2001; 80: 34650.
29. Weyand CM, Goronzy JJ. Association of MHC and rheumatoid
arthritis. HLA polymorphisms in phenotypic variants of rheu-
matoid arthritis. Arthritis Res 2000; 2: 2034.

30. Marotte H, Farge P, Gaudin P, Alexandre C, Mougin B,
Miossec P. The association between periodontal disease and
joint destruction in rheumatoid arthritis extends the link
between the HLA-DR shared epitope and severity of bone
destruction. Ann Rheum Dis 2006; 65: 9059.

31. Trombone AP, Claudino M, Colavite P, de Assis GF, Avila-
Campos MJ, Silva JS, et al. Periodontitis and arthritis interac-
tion in mice involves a shared hyper-inÔ¨Çammatory genotype and
functional immunological interferences. Genes Immun 2010; 11:
47989.

14. Zhang X, Pacheco-Tena C, Inman R. Microbe hunting in the

32. Arend WP, Dayer JM. Cytokines and cytokine or antagonists in

joints. Arthritis Rheum 2003; 49: 47982.

rheumatoid arthritis. Arthritis Rheum 1990; 33: 30515.

6

(page number not for citation purpose)

Citation: Journal of Oral Microbiology 2010, 2: 5784 - DOI: 10.3402/jom.v2i0.5784

33. Tolo K, Jorkjend L. Serum antibodies and loss of periodontal
bone in patients with rheumatoid arthritis. J Clin Periodontol
1990; 17: 28891.

34. Yusof Z, Porter SR, Greenman J, Scully C. Levels of serum IgG
against Porphyromonas gingivalis
in patients with rapidly
progressive periodontitis, rheumatoid arthritis and adult period-
ontitis. J Nihon Univ Sch Dent 1995; 37: 197200.

35. Wilbrink B, van de Heijden IM, Schouls LM, van Embden
JDA, Hazez JMW, Breedveld FC, et al. Detection of bacterial
DNA in joint samples from patients with undifferentiated
arthritis and reactive arthritis, using polymerase chain reaction
with universal 16S ribosomal RNA primers. Arthritis Rheum
1998; 41: 53543.

36. Braun J, Tuszewski M, Eggens U, Mertz A, Schauer-
Petrowskaja C, Doring E, et al. Nested polymerase chain
reaction strategy simultaneously targeting DNA sequences
of multiple bacterial species in inÔ¨Çammatory joint diseases. I.
Screening of synovial Ô¨Çuid samples of patients with spondyloar-
thropathies and other arthritides. J Rheumatol 1997; 24: 1092
100.

37. Gerard HC, Wang Z, Feng Wang G, El-Gabalawy H, Gold-
bach-Mansky R, Li Y, et al. Chromosomal DNA from a variety
of bacterial species is present in synovial tissue from patients
with various forms of arthritis. Arthritis Rheum 2001; 44: 1689
97.

38. Ogrendik M, Kokino S, Ozdemir F, Bird PS, Hamlet S. Serum
antibodies to oral anaerobic bacteria in patients with rheuma-
toid arthritis. Med Gen Med 2005; 7: 2.

39. Moen K, Brun JG, Valen M, Skartveit L, Eribe EK, Olsen I,
et al. Synovial
inÔ¨Çammation in active rheumatoid arthritis
and psoriatic arthritis facilitates trapping of a variety of oral
bacterial DNAs. Clin Exp Rheumatol 2006; 24: 65663.

40. Mikuls TR, Ayne JB, Reinhardt RA, Thiele GM, Maziarz E,
Cannella AC, et al. Antibody responses to Porphyromonas
gingivalis (P. gingivalis) in subjects with rheumatoid arthritis
and periodontitis. Int Immunopharmacol 2009; 9: 3842.

41. Martinez-Martinez RE, Abud-Mendoza C, PatinÀú o-Marin N,
Rizo-Rodriguez JC, Little JW, Loyola-Rodriguez JP. Detection
of periodontal bacterial DNA in serum and synovial Ô¨Çuid in
refractory rheumatoid arthritis patients. J Clin Periodontol
2009; 36: 100410.

42. Kinane DF, Riggio MP, Walker KF, MacKenzie D, Shearer B.
Bacteraemia following periodontal procedures. J Clin Period-
ontol 2005; 32: 70813.

43. de Pablo P, Chapple ILC, Buckley CD, Dietrich T. Periodontitis
in systemic rheumatic diseases. Nat Rev Rheumatol 2009; 5:
21824.

44. Pierce DL, Nishiyama S, Liang S, Wang M, TriantaÔ¨Ålou M,
TriantaÔ¨Ålou K, et al. Host adhesive activities and virulence of
novel Ô¨Åmbrial proteins of Porphyromonas gingivalis. Infect
Immun 2009; 77: 3294301.

45. Moen K, Brun JG, Madland TM, Tynning T, Jonsson R.
Immunoglobulin G and A antibody responses to Bacteroides
forsythus and Prevotella intermedia in sera and synovial Ô¨Çuids of
arthritis patients. Clin Diag Lab Immnunol 2003; 10: 104350.
46. Wegner N, Lundberg K, Kinloch A, Fisher B, Malmstro¬® m V,
Feldmann M, et al. Autoimmunity to speciÔ¨Åc citrullinated
proteins gives the Ô¨Årst clues to the etiology of rheumatoid
arthritis. Immunol Rev 2010; 233: 3454.

47. Wegner N, Wait R, Sroka A, Eick S, Nguyen KA, Lundberg K,
et al. Peptidylarginine deiminase from Porphyromonas gingivalis
citrullinates human Ô¨Åbrinogen and alpha-enolase: implications
for autoimmunity in rheumatoid arthritis. Arthritis Rheum
2010; 62: 266272.

RA and oral bacteria

periodontitis-associated rheumatoid arthritis. Med Hypotheses
2009; 72: 7325.

49. Hitchon CA, Chandad F, Ferucci ED, Willemze A,
Ioan-Facsinay A, van der Woude D, et al. Antibodies to
Porphyromonas gingivalis are associated with anticitrullinated
protein antibodies in patients with rheumatoid arthritis and
their relatives. J Rheumatol 2010; 37: 110512.

50. Lundberg K, Kinloch A, Fisher BA, Wegner N, Wait R, Charles
P, et al. Antibodies to citrullinated alpha-enolase peptide 1 are
speciÔ¨Åc for rheumatoid arthritis and cross-react with bacterial
enolase. Arthritis Rheum 2008; 58: 300919.

51. Bartold PM, Marino V, Cantley M, Haynes DR. Effect of
Porphyromonas gingivalis-induced inÔ¨Çammation on the devel-
opment of rheumatoid arthritis. J Clin Periodontol 2010; 37:
40511.

52. Pischon N, Ro¬® hner E, Hocke A, N‚ÄôGuessan P, Mu¬® ller HC,
Matziolis G, et al. Effects of Porphyromonas gingivalis on cell
cycle progression and apoptosis of primary human chondro-
cytes. Ann Rheum Dis 2009; 68: 19027.

53. Ghosh A, Park JY, Fenno C, Kapila YL. Porphyromonas
gingivalis, gamma interferon, and a proapoptotic Ô¨Åbronectin
matrix form a synergistic trio that induces c-Jun N-terminal
kinase 1-mediated nitric oxide generation and cell death. Infect
Immun 2008; 76: 551423.

54. Yu JJ, Ruddy MJ, Conti HR, Boonanantanasarn K, Gaffen SL.
The interleukin-17 receptor plays a gender-dependent role in
host protection against Porphyromonas gingivalis-induced peri-
odontal bone loss. Infect and Immun 2008; 76: 420613.

55. Yu JJ, Gaffen SL. Interleukin-17: a novel inÔ¨Çammatory cytokine
that bridges innate and adaptive immunity. Front Biosci 2008;
13: 1707.

56. Jacobson JJ, Patel B, Asher G, Woolliscroft JO, Schaberg D.
Oral staphylococcus in older subjects with rheumatoid arthritis.
J Am Geriatr Soc 1997; 45: 5903.

57. Jackson MS, Bagg J, Gupta MN, Sturrock RD. Oral carriage of
staphylococci in patients with rheumatoid arthritis. Rheumatol
1999; 38: 5725.

58. Ortiz P, Bissada NF, Palomo L, Han YW, Al-Zahrani MS,
Panneerselvam A, et al. Periodontal therapy reduces the severity
of active rheumatoid arthritis in patients treated with or
without tumor necrosis factors inhibitors. J Periodontol 2009;
80: 53540.

59. Ribeiro J, Leao A, Novaes AB. Periodontal

infection as a
possible severity factor for rheumatoid arthritis. J Clin Period-
ontol 2005; 32: 4126.

60. Al-Katma MK, Bissada NF, Bordeaux JM, Sue J, Askari AD.
Control of periodontal infection reduces the severity of active
rheumatoid arthritis. J Clin Rheumatol 2007; 13: 1347.

61. Modi DK, Chopra VS, Bhau U. Rheumatoid arthritis and
links and the emergence of dual

periodontitis: biological
purpose therapies. Indian J Den Res 2009; 20: 8690.

62. Fiedorczyk M, Klimiuk PA, Sierakowski S, Gindzienska-
Siesiewicz E, Chwiecko J. Serum matrix metalloproteinases
and tissue inhibitors of metalloproteinases in patients with early
rheumatoid arthritis. J Rheumatol 2007; 34: 8902.

63. Stone M, Fortin PR, Pacheco-Tena C, Inman RD. Should
tetracycline treatment be used more extensively for rheumatoid
arthritis? Meta analysis demonstrates clinical beneÔ¨Åt with
reduction in disease activity. J Rheumatol 2003; 30: 211222.

64. Sorsa T, Tjaderhane L, Konttinen YT, Lauhio A, Salo T,
Lee HM, et al. Matrix metalloproteinases: contribution to
pathogenesis, diagnosis and treatment of periodontal inÔ¨Çamma-
tion. Ann Med 2006; 38: 30621.

48. Liao F, Li Z, Wang Y, Shi B, Ging Z, Cheng X. Porphyromonas
gingivalis may play an important role in the pathogenesis of

65. Salvi GE, Williams RC, Offenbacher S. Nonsteroidal anti-
in the management of

inÔ¨Çammatory drugs as adjuncts

Citation: Journal of Oral Microbiology 2010, 2: 5784 - DOI: 10.3402/jom.v2i0.5784

(page number not for citation purpose)

7

Juan Pablo Loyola-Rodriguez et al.

periodontal diseases and peri-implantitis. Curr Opin Period-
ontol 1997; 4: 518.

66. Pillinger MH, Capodici C, Rosenthal P, Kheterpal N, Hanft S,
Philips MR, et al. Modes of action of aspirin-like drugs:
salicylates inhibit erk activation and integrin-dependent neu-
trophil adhesion. Proc Natl Acad Sci USA 1998; 95: 145405.
67. Lavagno L, Gunella G, Bardelli C, Spina S, Fresu LG, Viano I,
et al. Anti-inÔ¨Çammatory drugs and tumor necrosis factor-alpha
production from monocytes: role of transcription of factor
NF-kappa B and implication for rheumatoid arthritis therapy.
Eur J Pharmacol 2004; 501: 199208.

68. Albandar JM, DeNardin AM, Adesanya MR, Diehl SR, Winn
DM. Association between serum antibody levels to periodontal
pathogens and early-onset periodontitis. J Periodontol 2001; 72:
14639.

69. Ebersole JL, Cappelli D, Mathys EC, Steffen MJ, Singer
RE, Montgomery M, et al. Periodontitis in humans and

non-humans primates: oral-systemic linkage inducing acute
phase proteins. Ann Periodontol 2002; 7: 10211.

70. Bassetti S, Wasmer S, Hasler P, Vogt T, Nogarth D, Frei R, et al.
Staphylococcus aureus in patients with rheumatoid arthritis
under conventional and anti-tumor necrosis factor-alpha treat-
ment. J Rheumatol 2005; 32: 21259.

*Juan Pablo Loyola-Rodriguez
Head and Chairman
Mariano Avila# 295-2, Col.Tequisquiapam C.P. 78250
San Luis Potosƒ±¬¥, SLP, Me¬¥ xico
Tel: 52 444 8 26 23 61 ext. 102
Fax: 52 444 8 26 23 61 ext. 104
E-mail: jloyola@uaslp.mx

8

(page number not for citation purpose)

Citation: Journal of Oral Microbiology 2010, 2: 5784 - DOI: 10.3402/jom.v2i0.5784

